The Cancer Diagnostics Market is expected to be around US$ 31.20 Billion by 2028 at a CAGR of 12.1% in the given forecast period.

The rising prevalence of oncologic cases, continual technological improvements in diagnostics, and the growing desire for effective screening tests are all driving demand for screening instruments and procedures around the world. Additional factors expected to enhance market expansion throughout the forecast period include rising awareness and supportive government efforts.

Cancer is one of the major causes of mortality worldwide, and the disease’s frequency has been rising at an alarming rate. As a result, healthcare professionals are concentrating their efforts on the development of effective diagnostic and therapeutic solutions in order to determine the prevalence level. Treatment regimens with early detection have a higher success rate. As a result, healthcare institutions and market companies are pushing routine exams through various awareness efforts.

The global Cancer Diagnostics market is segregated on the basis of Test Type as Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, and Other Diagnostic Types. Based on Application the global Cancer Diagnostics market is segmented in Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer, and Others.

The global Cancer Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Cancer Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Abbott Laboratories, Agilent Technologies, Inc., Ambry Genetics Corporation, Applied Imaging, AstraZeneca PLC, AutoGenomics, Inc., BARD, A Becton, Dickinson Company, Bayer AG, Becton, Dickinson and Company, BioCurex, Inc., bioMeriux SA, Celara Diagnostics, Diagnostic Products Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, GE Healthcare, Genoptix, Inc., GlaxoSmithKline PLC, Hologic, Inc., Illumina, Inc., Pfizer, Inc., Philips Healthcare, QIAGEN GmbH, Siemens Healthineers, Thermo Fisher Scientific, Inc., and others are among the major players in the global Cancer Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Cancer Diagnostics Market has been segmented as below:

Cancer Diagnostics Market, By Test Type

• Diagnostic Imaging Tests
• Biopsy and Cytology Tests
• Tumor Biomarkers
• Other Diagnostic Types

Cancer Diagnostics Market, By Application

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Melanoma Cancer
• Prostate Cancer
• Liver Cancer
• Others

Cancer Diagnostics Market, By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Cancer Diagnostics Market, By Company

• Abbott Laboratories
• Agilent Technologies, Inc.
• Ambry Genetics Corporation
• Applied Imaging
• AstraZeneca PLC
• AutoGenomics, Inc.
• BARD, A Becton, Dickinson Company
• Bayer AG
• Becton, Dickinson and Company
• BioCurex, Inc.
• bioMeriux SA
• Celara Diagnostics
• Diagnostic Products Corporation
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• GE Healthcare
• Genoptix, Inc.
• GlaxoSmithKline PLC
• Hologic, Inc.
• Illumina, Inc.
• Pfizer, Inc.
• Philips Healthcare
• QIAGEN GmbH
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.

The report covers:

• Global Cancer Diagnostics market sizes from 2021 to 2028, along with CAGR for 2022-2028
• Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
• Global Cancer Diagnostics market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Cancer Diagnostics market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

Report Scope:

The global Cancer Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Cancer Diagnostics market share. Major industry players with significant revenue share include Abbott Laboratories, Agilent Technologies, Inc., Ambry Genetics Corporation, Applied Imaging, AstraZeneca PLC, AutoGenomics, Inc., BARD, A Becton, Dickinson Company, Bayer AG, Becton, Dickinson and Company, BioCurex, Inc., bioMeriux SA, Celara Diagnostics, Diagnostic Products Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, GE Healthcare, Genoptix, Inc., GlaxoSmithKline PLC, Hologic, Inc., Illumina, Inc., Pfizer, Inc., Philips Healthcare, QIAGEN GmbH, Siemens Healthineers, Thermo Fisher Scientific, Inc., and others.

Reasons to Buy this Report:

• Gain detailed insights on the Cancer Diagnostics industry trends
• Find complete analysis on the market status
• Identify the Cancer Diagnostics market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Customization

Customized report as per the requirement can be offered with appropriate recommendations

Below are our new reports:

Ventricular Assist Device Market

Continuous Renal Replacement Therapy (CRRT) Market

Dental Consumables Market

Digital Therapeutics (DTx) Market

Pulse Oximeter Market